» Articles » PMID: 35541033

Metastatic Carcinoma in Effusions

Overview
Journal Cytojournal
Date 2022 May 11
PMID 35541033
Authors
Affiliations
Soon will be listed here.
Abstract

Serous cavity may be involved by any neoplasm, including very rare examples of involvement by central nervous system tumors leading to a malignant effusion. The serous cavity lining is rich in lymphatics with lymphatic lacunae opening directly through narrow gaps (stoma) in the lining. Carcinomas mainly metastasize to serosa via the lymphatic vessels, which may be blocked leading to effusion. Primary carcinomas of organs such as lung, intestines, liver, ovary, etc., lined by serosal membranes may spread by direct extension, resulting in malignant effusions. As standard of practice, unless specified, cytopathologic examination of serous effusions implies detection of malignant cells. As compared to a surgical biopsy from a small focal area of an extensive serosal surface, effusion fluid from respective cavity exfoliates the cells from the entire serosal surface with minimal chance of sampling artifact. Because of this, effusion fluid cytology generally provides a higher diagnostic yield as compared to biopsy of the serous lining, as demonstrated by some studies. However, various challenges related to effusion fluid cytology makes the interpretation of effusion fluid cytology a field with potential misinterpretations, especially for those without proper experience or training. Developing and following a methodical approach is important for appropriate cytologic examination of effusion fluids. Proper approach may achieve definitive interpretation even without ancillary tests. However, lack of appropriate approach and processing may introduce a significant variation in interpretation due to combination of well-recognized diagnostic pitfalls, which may lead to lower reproducibility and even serious misinterpretations. Current review discusses in brief appropriate approach to processing and evaluating effusion fluid cytology for metastatic carcinoma. At general level, this is comparable to that of other specimens; however, it is critical to modify with reference to the limitations associated with effusion cytology.

Citing Articles

Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".

Kapoor S, Samanta S, Kaur K J Cytol. 2024; 41(2):96-104.

PMID: 38779601 PMC: 11108034. DOI: 10.4103/joc.joc_114_23.


Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning.

Tian F, Liu D, Wei N, Fu Q, Sun L, Liu W Nat Med. 2024; 30(5):1309-1319.

PMID: 38627559 PMC: 11108774. DOI: 10.1038/s41591-024-02915-w.


Multiple serous cavity effusion screening based on smear images using vision transformer.

Wang C, Wang X, Gao Z, Ran C, Li C, Ding C Sci Rep. 2024; 14(1):7395.

PMID: 38548898 PMC: 10978834. DOI: 10.1038/s41598-024-58151-2.


Deep Learning-Based Computational Cytopathologic Diagnosis of Metastatic Breast Carcinoma in Pleural Fluid.

Park H, Chong Y, Lee Y, Yim K, Seo K, Hwang G Cells. 2023; 12(14).

PMID: 37508511 PMC: 10377793. DOI: 10.3390/cells12141847.


Effusion cytology of metastatic carcinosarcoma.

Kundu R, Shastri M, Gupta P, Gupta N, Srinivasan R, Dey P Cytojournal. 2023; 20:14.

PMID: 37405308 PMC: 10316228. DOI: 10.25259/Cytojournal_30_2022.


References
1.
Sahn S . Pleural effusion in lung cancer. Clin Chest Med. 1982; 3(2):443-52. View

2.
Walts A, Said J . Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates. Acta Cytol. 1983; 27(4):408-16. View

3.
Motoyama T, Watanabe H . Ascitic fluid cytologic features of a malignant mixed mesodermal tumor of the ovary. Acta Cytol. 1987; 31(1):63-7. View

4.
Danner D, Gmelich J . A comparative study of tumor cells from metastatic carcinoma of the breast in effusions. Acta Cytol. 1975; 19(6):509-18. View

5.
Kohl O, Schaffer R, Doppl W . [Purulent pericarditis as an initial manifestation of esophageal carcinoma]. Dtsch Med Wochenschr. 1999; 124(13):381-5. DOI: 10.1055/s-2007-1024321. View